Clinical Trial Update: Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating Endostatin Adenovirus in combination with a checkpoint inhibitor for advanced head and neck cancer and esophageal cancer; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Head and Neck Cancer

Drugs mentioned

• Checkpoint inhibitor (unspecified)
• Endostatin Adenovirus (endostatin adenovirus vector)

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Cancer, Head and Neck Cancer (H&Amp;Amp;Amp;N) | Phase 1 | Status: NOT_YET_RECRUITING